Details
Nexium Control provides a course of treatment for relieving symptoms of heartburn, indigestion, and acid reflux. Each pack contains 7 tablets intended for short-term use. These tablets work by reducing stomach acid production, thereby managing discomfort associated with digestive acid-related conditions. It's important to follow the instructions provided for optimal results. GlaxoSmithKline (UK) Trading Limited GSK Consumer Healthcare (IE) Ltd., 980 Great West Road, Brentford, TW8 9GS, U. K. Or: 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland.
Show more
Ingredients
Ingredients: Each Gastro-Resistant Tablet contains 20 mg Esomeprazole (as Magnesium Trihydrate). Contains sucrose. See package leaflet for further information. As we are always looking to improve our products, our formulations change from time to time, so please always check the packaging before use.
Directions
Directions for use: Take one tablet once a day. Do not exceed this dose. The tablets should be swallowed whole. Do not chew or crush the tablets. May take 2-3 days for full effect. If your symptoms worsen or do not improve after taking this medicine for 14 days in a row, contact your doctor. Read the package leaflet before use. Oral use. Storage recommendation: Do not store above 30°C. Store in the original package in order to protect from moisture. Keep out of the sight and reach of children.
what does the product say20 mg Esomeprazole (as Magnesium Trihydrate) is an acid-fighting agent that helps treat frequent heartburn, indigestion, and acid reflux. It works by reducing the production of stomach acid, which is the excess stomach acid causing the symptoms, such as heartburn. The tablets are therefore suitable for short-term use, up to 3-4 days in a row. However, symptoms such as frequent heartburn may improve without further use, making them unsuitable for long-term use.
Show more esomeprazole (as Magnesium Trihydrate) is a prescription-only medicine used to treat frequent heartburn, indigestion, and acid reflux. It provides a course of treatment that can be taken for long-term relief of discomfort. These tablets work by reducing stomach acid, a process that helps to relieve heartburn, indigestion, and acid reflux. Common side effects include nausea and heartburn, which are less than 1%) needed.The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Lasting relief for frequent heartburn and acid reflux.
Always read the label and follow the directions for use.
Nexium 24HR 20 mg enteric coated tablets for the lasting symptomatic relief of frequent heartburn, acid regurgitation and other symptoms associated with gastro-oesophageal reflux.
Always take this medicine exactly as described in the Consumer Medicine Information leaflet or as your doctor or pharmacist have told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is one tablet a day. - Do not take more than this recommended dose of one tablet (20 mg) a day, even if you don't feel an improvement immediately. - You may need to take Nexium 24HR for a few days before experiencing the full effect. - Nexium 24HR should be taken for at least 7 days and up to 14 days. - Tell your pharmacist or doctor if you do not feel better while taking Nexium 24HR. If symptoms persist or recur within 2 weeks of completing the course, consult your doctor. Further examination may be required.
Always read the label, use only as directed. Tell your pharmacist or doctor if you notice any of the following and they worry you: nausea or vomiting, constipation, diarrhoea, headache, wind, stomach pain, skin rash, itchy skin, dizziness or dry mouth. These side effects are usually mild. Tell your pharmacist or doctor if you are taking any other medicines, including any that you buy without a prescription from your pharmacy, supermarket or health food shop. Some medicines may interfere with Nexium 24HR. Do not take Nexium 24HR if you are pregnant unless your doctor says so. Ask your doctor about the risks and benefits involved. It is not known if it is safe for you to take Nexium 24HR while you are pregnant. It may affect your baby. Do not take Nexium 24HR if you are breastfeeding. Ask your doctor for more information. It is not known if Nexium 24HR is excreted in breastmilk if you are breastfeeding.
Gumnailingin
Loading...Singapore store... Call your doctorgary pharmacy Pharmacist, doctor professional pharmacist, pharmacist professionalProduct Type: Other type: Nexium 24HR: enteric coated tablets for the treatment of frequent heartburn norexil... Nexium 24HR is a non-steroidal, non-selective, non-diarrheal, non-irritant drug that is used to treat frequent heartburn (occur more than 4 days a week). However, esomeprazole is a non-steroidal anti-inflammatory drug (NSAID) which has been shown to be effective for more than 8 weeks, and may be used for more than 24 hours in particular adults. When used to treat frequent heartburn, it may lead to an increase in heartburn symptoms such as a burning sensation, pain, itching or a sour taste in the mouth or loz... Nexium 24...Nexium 24HR Tablets: Tablets for 24 Hour Use: Nexium 24HR Tablets are a remedy for frequent heartburn, acid regurgitation and other symptoms associated with gastro-oesophageal reflux. These tablets are coated on the back of the tongue and are designed to be taken once or twice a day, with or without food. However, esomeprazole is a non-steroidal anti-inflammatory drug (NSAID). Esomeprazole is a proton pump inhibitor which reduces the stomach contents and relieves frequent heartburn. However, esomeprazole is a non-selective, gastrointestinal drug (GORD) which can also be taken in the morning or evening. The mechanism of action of Nexium 24HR is similar to that of ranitidine (esomeprazole). The active ingredient in Nexium 24HR is ranitidine which is a proton pump inhibitor that reduces the stomach contents and relieves frequent heartburn. Ranitidine is a non-steroidal anti-inflammatory drug (NSAID). The use of Nexium 24HR is also contraindicated in the following rare reactions: a sudden decrease or loss of hearing, temporary hearing loss, temporary paralysis, and seizures.What is acid? Acid is a substance with pH of 6.NEW YORK (CNNMoney.com) - A new deal between Pfizer Inc and Eli Lilly & Co. for a heartburn drug that could double the annual sales of Nexium and Prevacid could boost revenue for the U. S. health care industry.
Shares in the U. market, which includes the U. of Europe, jumped almost 5 percent in the week ended May 31 to close at Rs. 30,000. The S& P/ Nasdaq drugmaker has now increased its portfolio of medicines by 25 percent to close at Rs. 1,100.
Nexium, which is known as Prilosec, is used to treat pain and gastroesophageal reflux disease (GERD). It is also used in combination with other drugs to treat stomach ulcers and heartburn.
Eli Lilly has acquired the global sales of the drug and is now looking to market a new rival to Nexium for the U. market.
Lilly is the only U. pharmaceutical company to market an anti-acid pill in the U. market with the rights to develop and commercialize it for the U. Nexium, whose generic name is esomeprazole, is approved for use as a gastro-resistant acid blocker.
Eli Lilly has acquired the global sales of Nexium and Prevacid, and is now looking to market a new rival to Prilosec.
Nexium is already under patent protection and Prilosec is being manufactured by Eli Lilly in India.
AstraZeneca is the world's biggest pharmaceutical company and has been selling its medicines for more than 15 years.
As part of a merger deal for Pfizer, AstraZeneca is buying AstraZeneca for $1.6 billion, which will give Pfizer the largest discount on its total sales of $5 billion in six years. The transaction will allow the company to buy AstraZeneca and other companies that sell medicines on the same market.
Nexium, the world's second-biggest prescription drug, is the world's top-selling drug. It is also the world's second-biggest selling drug, after Protonix.
The U. market for a drug that is cheaper than other drugs is estimated at $1.4 billion a year and is expected to grow at a compound annual growth rate (CAGR) of 5.1 percent between 2012 and 2030.
Eli Lilly is also the world's biggest drugmaker. The company is the world's second-largest drugmaker, with $1.2 billion in sales in 2011.
AstraZeneca is one of the biggest drugmakers in the U. It is also one of the world's three largest drugmakers. It is a top-line partner of the U. pharmaceutical giant Pfizer and a partner of Merck & Co. It is also the world's largest drugmaker.
Eli Lilly is the world's biggest drugmaker, with a market share of 22.5 percent, at an annual growth rate of 7.3 percent in 2011.
The pharmaceutical industry is an age-old battle. It took an industry to take a new, cheaper, more efficient drug and change the way people use the drug. In the past few years, the number of people in the health care industry has grown to 6.3 billion.
The American Medical Association estimates that the number of prescriptions for the drugs will grow to 8.8 billion in the next year. The top 10 drugs in the class are listed at the top of the ranking and include Lipitor, Celebrex, Nexium, Pristiq, Zepbound, Celebrex and Claritin.
In the U. S., the pharmaceutical industry's ranking of the top 10 drugs grew to 9.3 percent from 10.2 percent in 2011.
The top 10 drugs in the class, also known as the "blue pill," are listed at the top of the ranking, with top products at the top of the ranking.
Among the top 10 drugs in the class, Nexium ranked third in the class with sales of $6.2 billion in 2012.
AstraZeneca and AstraZenecaAstraZeneca is the world's largest drugmaker. pharmaceutical giant AstraZeneca and is a partner of Merck and other companies that sell medicines on the same market.
AstraZeneca has a market share of 27.
Nexium, the brand name for esomeprazole, is a widely used medication for the treatment of a number of bacterial infections. It is commonly prescribed for diarrhea, nausea, heartburn and abdominal pain and is one of the most frequently used proton pump inhibitors (PPIs) globally. In the United States alone, Nexium has been available for sale for over two years, with approximately half of the prescriptions being for bacterial gastroesophageal reflux disease (GERD).
The global esomeprazole market has been experiencing steady growth since the approval of esomeprazole gel was received in the spring of 2003. The market was valued at USD 3.1 billion in 2023 and is projected to reach USD 6.8 billion by 2033. The market was valued at USD 3.3 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of at least 5% from 2024 to 2030. As of 2033,, the market is considered a developing stage, and there is no specific target market need to embrace the growth phase.
The esomeprazole market was segmented by the type of product and was was valued at around 50% market share in bothJenkins and Mavik. The Asia Pacific market was segmented by product and is expected to grow at a CAGR of 3.2% during the period 2024 to 2030[1][3].
The products segment, which is used primarily in pain management, was valued at around 50% in the Asia Pacific and was also included in the rest of the market. The rest of the product segment is expected to expand to more countries and is another important category for the market. The Asia Pacific product segment was also included in the rest of the market.
The proton pump inhibitor segment, which is also the product, was valued at around 50% in the Asia Pacific and was also included in the rest of the market. The rest of the product segment is expected to be the most studied product because of its potential uses[1].
The global esomeprazole market is projected to grow at a CAGR of 5.9% from 2024 to 2030. The market is expected to reach USD 6.8 billion in 2027 and is not specific target. The market is research and development based, and it is estimated that no specific market is needed[1][3].
The aetiomeprazole market, which is the segment of the business, is segmented by product and is expected to reach USD 3.1 billion by 2033. The Asia Pacific product segment is expected to grow at the 5% CAGR during the period 2024 to 2030[3].
Nexium, the brand name for esomeprazole, is a proton pump inhibitor used primarily in the treatment of diarrhea. It is a main component of the PPI gastric and duodenal acid suppression drugs, which are mainly used for heartburn, gastroesophageal reflux, and esophagitis treatment. Nexium is also available in the combination therapy of Esomeprazole and Omeprazole. The combination therapy is a newer drug that uses Esomeprazole and Omeprazole as main ingredient[5].
The main drivers of the esomeprazole market are studied and are expected to continue being the most used proton pump inhibitor segment. The product segment is expected to increase at least 5-7 percentage points during the period. The Asia Pacific product segment is expected to be the most studied in the market[3].
The Asia Pacific product segment is expected to grow at the 5% CAGR during the period. The Asia Pacific product segment is the most studied product in the market because of its potential uses. The rest of the product segment is expected to be the most developed, and is a non-core product.
The preopy product segment was valued at around USD 9 million in the Asia Pacific and is expected to grow at a CAGR of 5% during the period.
Stade de France Pharmacy